34,854 people played the daily Crossword recently. Can you solve it faster than others?34,854 people played the daily Crossword recently. Can you solve it faster than others?
BioCity Biopharma’s selective endothelin receptor type A (ETA) antagonist has reduced excess proteins in the urine of patients with diabetic kidney disease (DKD), hitting a primary endpoint of a ...
The THUNDERBALL CKD programme consists of the completed studies FIDELIO-DKD and FIGARO-DKD, as well as the ongoing studies FIND-CKD, FIONA, FIONA-OLE, FINE-ONE, and the phase II study CONFIDENCE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback